RXI Pharma (RXII) Reports In-Line Q3 EPS

November 10, 2016 7:24 AM EST
Get Alerts RXII Hot Sheet
Trade RXII Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

RXI Pharma (NASDAQ: RXII) reported Q3 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

For earnings history and earnings-related data on RXI Pharma (RXII) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment